Innoviva Inc (INVA)

Innoviva (INVA) Stock Price & Analysis


INVA Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$10.64 - $15.67
Previous Close$13.17
Average Volume (3M)704.71K
Market Cap
Enterprise Value$1.16B
Total Cash (Recent Filing)$144.05M
Total Debt (Recent Filing)$444.69M
Price to Earnings (P/E)5.8
Jul 26, 2023
Dividend YieldN/A
Share Statistics
EPS (TTM)2.25
Shares Outstanding65,504,384
10 Day Avg. Volume670,086
30 Day Avg. Volume704,712
Standard Deviation0.10
Financial Highlights & Ratios
Price to Book (P/B)3.09
Price to Sales (P/S)11.30
Price to Cash Flow (P/CF)24.80
P/FCF Ratio16.80
Enterprise Value/Market CapN/A
Enterprise Value/Revenue3.66
Enterprise Value/Gross Profit3.57
Enterprise Value/Ebitda3.66
Price Target Upside70.45% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1



Risk Analysis

Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Innoviva Inc’s price range in the past 12 months?
Innoviva Inc lowest stock price was $10.64 and its highest was $15.67 in the past 12 months.
    What is Innoviva Inc’s market cap?
    Currently, no data Available
    When is Innoviva Inc’s upcoming earnings report date?
    Innoviva Inc’s upcoming earnings report date is Jul 26, 2023 which is in 50 days.
      How were Innoviva Inc’s earnings last quarter?
      Innoviva Inc released its earnings results on May 09, 2023. The company reported $0.42 earnings per share for the quarter, beating the consensus estimate of $0.23 by $0.19.
        Is Innoviva Inc overvalued?
        According to Wall Street analysts Innoviva Inc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Innoviva Inc pay dividends?
          Innoviva Inc pays a Semiannually dividend of $0.25 which represents an annual dividend yield of N/A. See more information on Innoviva Inc dividends here
            What is Innoviva Inc’s EPS estimate?
            Innoviva Inc’s EPS estimate is $0.26.
              How many shares outstanding does Innoviva Inc have?
              Innoviva Inc has 65,504,390 shares outstanding.
                What happened to Innoviva Inc’s price movement after its last earnings report?
                Innoviva Inc reported an EPS of $0.42 in its last earnings report, beating expectations of $0.23. Following the earnings report the stock price went up 5.536%.
                  Which hedge fund is a major shareholder of Innoviva Inc?
                  Among the largest hedge funds holding Innoviva Inc’s share is Woodline Partners LP. It holds Innoviva Inc’s shares valued at 6M.


                    Innoviva Stock Smart Score

                    The Innoviva stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                    Learn more about TipRanks Smart Score

                    Company Description

                    Innoviva Inc

                    Innoviva, Inc. is engaged in the development, commercialization, and financial management of bio-pharmaceuticals. Its portfolio includes Relvar Breo Ellipta, which is a once-daily combination medicine consisting of a long-acting beta2 agonist, vilanterol, and an inhaled corticosteroid, fluticasone furoate; and Anoro Ellipta, a once-daily medicine combining a long-acting muscarinic antagonist, umeclidinium bromide, LABA, VI. The company was founded by P. Roy Vagelos, Mathai Mammen, and George M. Whitesides in November 1996 and is headquartered in Burlingame, CA.


                    Top 5 ETFs holding INVA

                    Market Value
                    Smart Score
                    Vanguard Total Stock Market ETF
                    Vanguard Health Care ETF
                    iShares U.S. Pharmaceuticals ETF
                    iShares Core S&P Total U.S. Stock Market ETF
                    Schwab U.S. Broad Market ETF
                    Up to five ETFs with an Outperform Smart Score that hold INVA. The ETFs are listed according to market value of INVA within the ETF


                    Forecast EPS vs Actual EPS

                    Similar Stocks
                    Price & Change
                    Aclaris Therapeutics
                    Pliant Therapeutics
                    Amneal Pharmaceuticals
                    Belite Bio, Inc. ADR

                    Popular Stocks

                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis